These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study. Jacobs L; O'Malley JA; Freeman A; Reese P Arch Neurol; 1983 Oct; 40(11):683-6. PubMed ID: 6354150 [No Abstract] [Full Text] [Related]
11. Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis. Mora JS; Munsat TL; Kao KP; Finison LJ; Hedlund W; Bradley GA; Scheife R; Georgiades JA Neurology; 1986 Aug; 36(8):1137-40. PubMed ID: 3526180 [TBL] [Abstract][Full Text] [Related]
12. Intrathecal beta-interferon in multiple sclerosis. Milanese C; Salmaggi A; la Mantia L; Corridori F; Nespolo A Lancet; 1988 Sep; 2(8610):563-4. PubMed ID: 2900935 [No Abstract] [Full Text] [Related]
13. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
14. Interferon beta for multiple sclerosis. Connelly JF Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001 [TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis, overall and by drug and disease type. Nikfar S; Rahimi R; Abdollahi M Clin Ther; 2010 Oct; 32(11):1871-88. PubMed ID: 21095482 [TBL] [Abstract][Full Text] [Related]
16. A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG). Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH Mult Scler; 1995 Jun; 1(2):118-35. PubMed ID: 9345462 [TBL] [Abstract][Full Text] [Related]
17. The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis. Axelsson M; Mattsson N; Malmeström C; Zetterberg H; Lycke J J Neuroimmunol; 2013 Nov; 264(1-2):100-5. PubMed ID: 24125567 [TBL] [Abstract][Full Text] [Related]
18. Alpha interferon clinical trial for multiple sclerosis: design considerations. Alter M; Greenstein J; Camenga D; LaRue L Neuroepidemiology; 1987; 6(1-2):85-92. PubMed ID: 3306431 [TBL] [Abstract][Full Text] [Related]
19. Oligoclonal "fingerprint" of CSF IgG in multiple sclerosis patients is not modified following intrathecal administration of natural beta-interferon. Confavreux C; Chapuis-Cellier C; Arnaud P; Robert O; Aimard G; Devic M J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1308-12. PubMed ID: 3794738 [TBL] [Abstract][Full Text] [Related]